Egeneration upon loss of Presynaptic proteins Munc18-1, Syntaxin-1, or SNAP-25. J Neurosci 37:4525539. doi:10.1523/JNEUROSCI.3352-16.2017 54. Law C, Schaan Profes M, Levesque M et al (2016) Normal molecular specification and neurodegenerative disease-like death of spinal neurons lacking the SNARE-associated synaptic protein Munc18-1. J Neurosci 36: 56176. doi:10.1523/JNEUROSCI.1964-15.2016 55. Ohshima T, Hirasawa M, Tabata H et al (2007) Cdk5 is essential for multipolar-to-bipolar transition for the duration of radial neuronal migration and proper dendrite development of pyramidal neurons within the cerebral cortex. Improvement 134:2273282. doi:10.1242/dev.02854 56. Kawauchi T, Chihama K, Nabeshima Y-I, Hoshino M (2006) Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 8:176. doi:10.1038/ncb1338 57. Schubert J, Siekierska A, Langlois M et al (2014) Mutations in STX1B, encoding a presynaptic protein, bring about fever-associated epilepsy syndromes. Nat Genet 46:1327332. doi:10.1038/ng.3130 58. Nakamura K, Iwata Y, Anitha A et al (2011) Replication study of Japanese cohorts supports the function of STX1A in autism susceptibility. Prog NeuroPsychopharmacol Biol Psychiatry 35:45458. doi:ten.1016/j.pnpbp.2010.11.033 59. Cartier E, Hamilton PJ, Belovich AN et al (2015) Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. EBioMedicine two:13546. doi:ten.1016/j.ebiom.2015.01.
Head et al. Acta Recombinant?Proteins Arginase-1 Protein Neuropathologica Communications (2017) five:93 DOI ten.1186/s40478-017-0499-RESEARCHOpen AccessCerebrovascular pathology in Down syndrome and Alzheimer diseaseElizabeth Head1*, Michael J. Phelan2, Eric Doran3, Ronald C. Kim4, Wayne W. Poon5, Frederick A. Schmitt1,7 and Ira T. Lott3,AbstractPeople with Down syndrome (DS) are at higher danger for building Alzheimer disease (AD) with age. Commonly, by age 40 years, a lot of people with DS have enough neuropathology for an AD diagnosis. Interestingly, atherosclerosis and hypertension are atypical in DS with age, suggesting the lack of those vascular threat components might be linked with decreased cerebrovascular pathology. However, because the further copy of APP leads to increased beta-amyloid peptide (A) accumulation in DS, we hypothesized that there will be more in depth and widespread cerebral amyloid angiopathy (CAA) with age in DS relative to sporadic AD. To test this hypothesis CAA, atherosclerosis and arteriolosclerosis have been made use of as measures of cerebrovascular pathology and compared in post mortem tissue from folks with DS (n = 32), sporadic AD (n = 80) and controls (n = 37). CAA was observed with considerably larger frequencies in brains of people with DS in comparison with sporadic AD and controls. Atherosclerosis and arteriolosclerosis have been uncommon inside the circumstances with DS. CAA in DS can be a target for future interventional clinical trials. Key phrases: Arteriolosclerosis, Atherosclerosis, Cerebral amyloid angiopathy, Trisomy 21, Vascular threat factorsIntroduction People today with Down syndrome (DS) are at larger risk for developing Alzheimer illness (AD), which can be thought to become mainly resulting from the overexpression of amyloid precursor protein [19, 46]. Beta-amyloid (A) plaques and neurofibrillary tangles are commonly observed by 40 years of age (reviewed in [27], with dementia onset most typically occurring virtually a decade later [26, 35, 36, 52]. As much as 55 of peop.